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Following publication of the aforementioned article, the authors noted a minor error in Table 1 and two small errors in Table 2. In Table [1](#Tab1){ref-type="table"}, the Eron Class III Clinical Criteria should read CrCl \<30 mL/min or on dialysis, not CrCl \<20 mL/min. In Table [2](#Tab2){ref-type="table"}, Distribution of SOLO patients in modified Eron Classes I--III, the number of outpatients receiving vancomycin (VAN) in Class I should be 111, not 11. The total number of inpatients (Class I--III) was omitted, *n* = 1143 (59.8%).Table 1Clinical criteria used to define modified Eron Classes I--IVEron classClinical criteriaIVBacteremia (positive blood culture); or\
Absolute total neutrophils count \<500IIIMeeting SIRS criteria\
CrCl \<30 mL/min or on dialysis\
ALT/AST \>10-times ULN\
Heart rate \>90/min, breath rate \>20/min, or systolic BP \<90 mmHg; or\
CancerIIAge ≥75 years old\
Glucose \>11.1 mmol/L\
Congestive heart failure at the randomization\
30 mL/min \< CrCl \<60 mL/min\
Hepatitis (excluding AST/ALT \>10-times ULN)\
Peripheral vascular disease\
Diabetes mellitus\
Fever (temperature \>38.0 °C); or\
BMI ≥30 kg/m^2^IFor the patients who didn't meet Classes II--IV*ALT* alanine transaminase, *AST* aspartate transaminase, *BMI* body mass index, *BP* blood pressure, *CrCl* creatinine clearance, *SIRS* systemic inflammatory response syndrome, *ULN* upper limit of normalTable 2Distribution of SOLO patients in modified Eron Classes I--III (mITT population, *n* = 1959)Class IClass IIClass IIITotal (Class I--III)SOLO mITT (*n* = 1959)520 (26.5%)790 (40.3%)600 (30.6%)1910Inpatients, *n* (%)301 (57.9%)431 (54.6%)411 (68.5%)1143 (59.8%)ORI, *n*144224203571VAN, *n*157207208572Outpatients, *n* (%)219 (42.1%)359 (45.4%)189 (31.5%)767 (40.2%)ORI, *n*10818289379VAN, *n*111177100388*mITT* modified intent-to-treat, *ORI* oritavancin, *VAN* vancomycin

The online version of the original article can be found under doi:10.1007/s40121-016-0119-9.
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